Rapid and safe point-of-care blood testing devices are used to perform diagnostics tests such as protein test, blood metabolites test, hormone blood test, INR or prothrombin test (PT), hemoglobin test and also to test glucose level in blood. Abbott i-STAT handheld analyzer is one such device that provides lab-quality results in minutes. According to the latest market report published by Future Market Insights, the global point-of-care blood testing devices market is driven by factors such as:
- increasing awareness among the population regarding diabetes in adults and children
- increasing incidence of diabetes
- different types of medical tests
- the advancements in technologies
- the development of blood testing devices such as point-of-care blood testing analyzer and point-of-care diabetes analyzer
- increasing awareness among the people
- increasing growth in the number of diabetic patients
- increasing demand for such devices
However, the lack of knowledge and lack of experience in using these advanced technologies can act as a restraint to the market growth.
This global market is classified on the basis of product type, technology type and distribution channel. While the product type segment includes point-of-care analyzers related to diabetes, coagulation, and Hematology POC Reader, the technologies segment includes printer devices, touch-screen devices and hand-held devices. Based on distribution channel, the market is divided into retail prices, hospitals, clinics, health centers and homecare settings.
Geographically, North America is expected to lead the market, owing to factors such as better economic conditions, better healthcare facilities and better government initiatives. The European market is expected to hold the second largest market share followed by Latin America due to increasing awareness and increasing adoption of advanced technologies.
Some of the key players in this point-of-care blood testing devices market are F. Hoffmann-La Roche Ltd., Getein Biotech, Inc., Abbott Diagnostics Inc., Callegari Srl, Goldsite Diagnostics Inc, TaiDoc Technology Corporation, Alere Inc, and MED TRUST among others.